Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: A case-control study and meta-analysis

PLoS ONE

Volumn 9, Issue 11, 2014, Pages

  Liao, Dan ^a,b   Wu, Yongfu ^a,b   Pu, Xingxiang ^c   Chen, Hua ^a,b   Luo, Shengqun ^a,b   Li, BinBin ^a,b   Ding, Congcong ^a,b   Huang, Guo Liang ^a,b   He, Zhiwei ^a,b  

^a GUANGDONG MEDICAL UNIVERSITY   (China)

^b Key Laboratory for Medical Molecular Diagnostics of Guangdong Province   (China)

^c HUNAN CANCER HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; CYCLIN D1; GUANIDINE; CCND1 PROTEIN, HUMAN;

ADULT; ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; BIOINFORMATICS; CANCER RISK; CAUCASIAN; CCND1 GENE; CHINESE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DOMINANT INHERITANCE; FEMALE; GENE FREQUENCY; GENETIC CORRELATION; GENETIC MODEL; GENETIC VARIABILITY; HOSPITAL BASED CASE CONTROL STUDY; HUMAN; MAJOR CLINICAL STUDY; MALE; NASOPHARYNX CARCINOMA; RACE DIFFERENCE; RECESSIVE INHERITANCE; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE CONTROL STUDY; CHINA; ETHNOLOGY; GENETIC ASSOCIATION; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; MIDDLE AGED; NASOPHARYNX TUMOR;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CYCLIN D1; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84912143681     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0113299     Document Type: Article

References (31)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
2. GLOBOCAN2012, IARC.
3. Cho WC (2007) Nasopharyngeal carcinoma: Molecular biomarker discovery and progress. Mol Cancer 6: 1.
4. Bates S, Peters G (1995) Cyclin D1 as a cellular proto-oncogene. Semin Cancer Biol 6: 73-82.
5. Hartwell LH, Kastan MB (1994) Cell cycle control and cancer. Science 266: 1821-1828.
6. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.
7. Bae DS, Cho SB, Kim YJ, Whang JD, Song SY, et al. (2001) Aberrant expression of cyclin D1 is associated with poor prognosis in early stage cervical cancer of the uterus. Gynecol Oncol 81: 341-347.
8. Barnes DM, Gillett CE (1998) Cyclin D1 in breast cancer. Breast Cancer Res Treat 52: 1-15.
9. Xiao-Ping H, Tie-Hua R, Peng L, Qiu-Liang W, Guang-Yu Y, et al. (2006) Cyclin D1 overexpression in esophageal cancer from southern China and its clinical significance. Cancer Lett 231: 94-101.
10. Jin M, Inoue S, Umemura T, Moriya J, Arakawa M, et al. (2001) Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in nonsmall cell lung cancer at stages I and II. Lung Cancer 34: 207-218.
11. Palmqvist R, Stenling R, Oberg A, Landberg G (1998) Expression of cyclin D1 and retinoblastoma protein in colorectal cancer. Eur J Cancer 34: 1575-1581.
12. Callender T, el-Naggar AK, Lee MS, Frankenthaler R, Luna MA, et al. (1994) PRAD-1 (CCND1)/cyclin D1 oncogene amplification in primary head and neck squamous cell carcinoma. Cancer 74: 152-158.
13. Sameer AS, Parray FQ, Dar MA, Nissar S, Banday MZ, et al. (2013) Cyclin D1 G870A polymorphism and risk of colorectal cancer: A case control study. Mol Med Rep 7: 811-815.
14. Betticher DC, Thatcher N, Altermatt HJ, Hoban P, Ryder WD, et al. (1995) Alternate splicing produces a novel cyclin D1 transcript. Oncogene 11: 1005-1011.
15. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES (2006) Cyclin D1: Polymorphism, aberrant splicing and cancer risk. Oncogene 25: 1620-1628.
16. Lu F, Gladden AB, Diehl JA (2003) An alternatively spliced cyclin D1 isoform, cyclin D1b, is a nuclear oncogene. Cancer Res 63: 7056-7061.
17. Solomon DA, Wang Y, Fox SR, Lambeck TC, Giesting S, et al. (2003) Cyclin D1 splice variants. Differential effects on localization, RB phosphorylation, and cellular transformation. J Biol Chem 278: 30339-30347.
18. Wu Y, Fu H, Zhang H, Huang H, Chen M, et al. (2014) Cyclin D1 (CCND1) G870A polymorphisms and cervical cancer susceptibility: A meta-Analysis based on ten case-control studies. Tumour Biol 35: 6913-6918.
19. Shih LC, Tsai CW, Tsai MH, Tsou YA, Chang WS, et al. (2012) Association of cyclin D1 genotypes with nasopharyngeal carcinoma risk. Anticancer Res 32: 1093-1098.
20. Sui J, Gao W, Li XJ, Ma J, Ren YX, et al. (2009) [Cyclin D1 gene G870A polymorphism and susceptibility to nasopharyngeal carcinoma]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 44: 227-231.
21. Catarino RJ, Breda E, Coelho V, Pinto D, Sousa H, et al. (2006) Association of the A870G cyclin D1 gene polymorphism with genetic susceptibility to nasopharyngeal carcinoma. Head Neck 28: 603-608.
22. Deng L, Zhao XR, Pan KF, Wang Y, Deng XY, et al. (2002) Cyclin D1 polymorphism and the susceptibility to NPC using DHPLC. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 34: 16-20.
23. Catarino R, Pereira D, Breda E, Coelho A, Matos A, et al. (2008) Oncogenic virus-Associated neoplasia: A role for cyclin D1 genotypes influencing the age of onset of disease? Biochem Biophys Res Commun 370: 118-122.
24. Huang GL, Lu Y, Pu XX, He YX, Chen ML, et al. (2013) Association study between miR-149 gene polymorphism and nasopharyngeal carcinoma. Biomed Rep 1: 599-603.
25. Yu MC, Yuan JM (2002) Epidemiology of nasopharyngeal carcinoma. Semin Cancer Biol 12: 421-429.
26. Lo KW, Huang DP (2002) Genetic and epigenetic changes in nasopharyngeal carcinoma. Semin Cancer Biol 12: 451-462.
27. Hall M, Peters G (1996) Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv Cancer Res 68: 67-108.
28. Liu J, Liao Q, Zhang Y, Sun S, Zhong C, et al. (2012) Cyclin D1 G870A polymorphism and lung cancer risk: A meta-Analysis. Tumour Biol 33: 1467-1476.
29. Wang W, Zhao Y, Yang J, Lin B, Gu H, et al. (2013) Cyclin D1 polymorphism and oral cancer: A meta-Analysis. Mol Biol Rep 40: 87-95.
30. Sergentanis TN, Economopoulos KP (2011) Cyclin D1 G870A polymorphism and breast cancer risk: A meta-Analysis comprising 9,911 cases and 11,171 controls. Mol Biol Rep 38: 4955-4963.
31. Li M, Dai W, Zhou H (2013) Cyclin D1 G870A polymorphism and risk of nasopharyngeal carcinoma: A meta-Analysis. ScientificWorldJournal 2013: 689048.